Xingchun Han
23Patents
6h-index
28Co-inventors
65Inventor score
Filing activity: Nov 18, 2008 → Nov 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8076482B2 | 3,3′-spiroindolinone derivatives | Human Necessities | 26 | Active |
| US9458153B2 | Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection | Chemistry; Metallurgy | 19 | Active |
| US7776875B2 | Spiroindolinone derivatives | Human Necessities | 17 | Active |
| US10093671B2 | 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection | Human Necessities | 12 | Active |
| US9637485B2 | 6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection | Human Necessities | 8 | Active |
| US7928233B2 | Spiroindolinone pyridine derivatives | Human Necessities | 6 | Active |
| US9920049B2 | Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection | Human Necessities | 4 | Active |
| US9845322B2 | Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection | Human Necessities | 3 | Active |
| US10336751B2 | Tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection | Human Necessities | 3 | Active |
| US10053461B2 | Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection | Chemistry; Metallurgy | 3 | Active |
| US10150740B2 | 6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection | Chemistry; Metallurgy | 3 | Active |
| US9890167B2 | Pyrazine compounds for the treatment of infectious diseases | Chemistry; Metallurgy | 3 | Active |
| US9949966B2 | Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection | Chemistry; Metallurgy | 2 | Active |
| US11191775B2 | PAPD5 and PAPD7 inhibitors for treating a hepatitis B infection | Chemistry; Metallurgy | 2 | Active |
| US11104674B2 | Tetrahydropyridopyrimidines for the treatment of HBV infection | Chemistry; Metallurgy | 1 | Active |
| US11447489B2 | Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B virus infection | Chemistry; Metallurgy | 0 | Active |
| US11225482B2 | Dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis B virus infection | Chemistry; Metallurgy | 0 | Active |
| US10683299B2 | Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseases | Chemistry; Metallurgy | 0 | Active |
| US12421211B2 | Heterocyclic compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US11858912B2 | Heterocyclic compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US10968218B2 | Tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis B virus infection | Human Necessities | 0 | Active |
| US11168086B2 | Methods of synthesizing pyrazine compounds | Chemistry; Metallurgy | 0 | Active |
| US10781206B2 | Tetrahydropyrazolopyridine compounds for the treatment of infectious diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.